Domingo Andrés Pascual Figal-rekin lankidetzan egindako argitalpenak (3)

2022

  1. A Multicenter, Phase 2, Randomized, Placebo-Controlled, Double-Blind, Parallel-Group, Dose-Finding Trial of the Oral Factor XIa Inhibitor Asundexian to Prevent Adverse Cardiovascular Outcomes After Acute Myocardial Infarction

    Circulation, Vol. 146, Núm. 16, pp. 1196-1206

2012

  1. Comments on the ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012. A report of the task force of the clinical practice guidelines committee of the Spanish Society of Cardiology

    Revista Espanola de Cardiologia, Vol. 65, Núm. 10, pp. 874-878

2011

  1. Comments on the ESC/EAS guidelines for the management of dyslipidaemias 2011. A report of the task force of the clinical practice guidelines committee of the Spanish society of cardiology

    Revista Espanola de Cardiologia, Vol. 64, Núm. 12, pp. 1090-1095